XML 62 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Reporting (Selected Financial Information by Reporting Segment) (Details)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
segment
Sep. 30, 2020
USD ($)
Segment Reporting Information [Line Items]        
Number of Reportable Segments | segment     2  
Net revenues:        
Net revenues $ 112,198 $ 83,431 $ 316,881 $ 253,925
Gross profit (loss):        
Gross Profit 51,183 36,508 143,505 106,508
Operating expenses 26,414 32,991 97,870 98,433
Income (loss) from operations 24,769 3,517 45,635 8,075
Non-operating income (expenses) 12,877 3,561 11,342 3,304
Income (loss) before income taxes 37,646 7,078 56,977 11,379
Finished Pharmaceutical Products        
Net revenues:        
Net revenues 108,990 81,335 301,594 243,568
Gross profit (loss):        
Gross Profit 54,602 39,546 149,502 113,793
API        
Net revenues:        
Net revenues 3,208 2,096 15,287 10,357
Gross profit (loss):        
Gross Profit $ (3,419) $ (3,038) $ (5,997) $ (7,285)